Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting

3d ago

CLNN

PremiumPress Releases

Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8®

1M ago

CLNN

PremiumPress Releases

Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights

1M ago

CLNN

PremiumCompany Announcements

Clene Announces Breakthrough CNM-Au8 Treatment Results

2M ago

CLNN

PremiumPress Releases

Clene Presents Clinical Results of CNM-Au8® 30mg Treatment From Visionary-MS Trial Long-Term Extension at Annual ACTRIMS Forum 2024

2M ago

CLNN

PremiumCompany Announcements

Clene’s CNM-Au8 Shows Promise in ALS Survival Rates

2M ago

CLNN

More CLNN News >

CLNN News on the Web

2024-04-17

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

InvestorPlace

Neutral

2024-03-26

3 Penny Stocks That Could Be Multibaggers in the Making: March Edition

InvestorPlace

Neutral

2024-03-19

IBN Announces First in Human Podcast Featuring Clene Inc. CEO Rob Etherington

Yahoo Finance

Neutral

2024-03-15

Buy Rating Affirmed for Clene Amid Positive ALS Drug Data and Market Dynamics

TipRanks News

Bullish

2024-03-15

Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8®

Yahoo Finance

Neutral

2024-03-13

Clene Inc. (CLNN) Reports Q4 Loss, Tops Revenue Estimates

Zacks

Neutral

2024-03-07

Clene to Present at the 36th Annual ROTH Conference

Yahoo Finance

Neutral

2024-02-29

Buy Rating Affirmed for Clene’s CNM-Au8 on Promising Long-Term Clinical Outcomes

TipRanks News

Neutral

News Score - Last 7 Days

Neutral

CLNN

Sector Average

Media Buzz

This Week1 articles

Weekly Average1 articles

News Sentiment

This Week50%

Sector Average64%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CLNN’s Media Buzz Sentiment?

1 articles about CLNN were published this week. In an average week, 1 articles are published.

What is CLNN’s weekly average amount of articles?

In an average week, 1 articles about CLNN are published.

What is CLNN’s News Sentiment?

50% of articles about CLNN were positive this week, compared to its sector average of 64%.

Healthcare Stocks that are Trending in the News

CGEMCullinan Management

MRNSMarinus

EWEdwards Lifesciences

ELVElevance Health

ABTAbbott Labs

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing